 Betsy Risendal
Concepts (191)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Neoplasms | 18 | 2023 | 2106 | 2.440 |
Why?
| | Cancer Survivors | 5 | 2023 | 204 | 2.090 |
Why?
| | Patient Navigation | 4 | 2022 | 64 | 1.960 |
Why?
| | Survivors | 12 | 2015 | 410 | 1.700 |
Why?
| | Breast Neoplasms | 23 | 2022 | 1865 | 1.510 |
Why?
| | Colorectal Neoplasms | 7 | 2022 | 617 | 1.400 |
Why?
| | Community-Based Participatory Research | 1 | 2023 | 130 | 0.800 |
Why?
| | Delivery of Health Care | 8 | 2023 | 835 | 0.770 |
Why?
| | Health Plan Implementation | 3 | 2018 | 132 | 0.730 |
Why?
| | Early Detection of Cancer | 7 | 2023 | 339 | 0.690 |
Why?
| | Patient Care Planning | 4 | 2015 | 139 | 0.590 |
Why?
| | Patient Advocacy | 1 | 2017 | 66 | 0.560 |
Why?
| | Quality of Life | 4 | 2023 | 2359 | 0.540 |
Why?
| | Specialization | 1 | 2015 | 115 | 0.470 |
Why?
| | Registries | 2 | 2020 | 1763 | 0.430 |
Why?
| | Physicians, Primary Care | 1 | 2015 | 222 | 0.410 |
Why?
| | Health Equity | 2 | 2023 | 53 | 0.400 |
Why?
| | Research Design | 3 | 2023 | 930 | 0.400 |
Why?
| | Self Care | 1 | 2014 | 351 | 0.400 |
Why?
| | Mass Screening | 6 | 2022 | 1012 | 0.390 |
Why?
| | Humans | 54 | 2023 | 115038 | 0.390 |
Why?
| | Cross-Sectional Studies | 10 | 2020 | 4411 | 0.360 |
Why?
| | Middle Aged | 29 | 2022 | 26826 | 0.350 |
Why?
| | Health Knowledge, Attitudes, Practice | 5 | 2014 | 1184 | 0.350 |
Why?
| | Adaptation, Psychological | 1 | 2014 | 547 | 0.350 |
Why?
| | Indians, North American | 3 | 1999 | 570 | 0.350 |
Why?
| | Chronic Disease | 2 | 2015 | 1591 | 0.340 |
Why?
| | Patient-Centered Care | 1 | 2014 | 474 | 0.340 |
Why?
| | Aged | 21 | 2022 | 19119 | 0.340 |
Why?
| | Weight Gain | 1 | 2013 | 451 | 0.340 |
Why?
| | Surveys and Questionnaires | 9 | 2022 | 4631 | 0.310 |
Why?
| | Program Evaluation | 4 | 2022 | 825 | 0.300 |
Why?
| | Logistic Models | 10 | 2019 | 1839 | 0.300 |
Why?
| | Family Health | 1 | 2008 | 194 | 0.290 |
Why?
| | Continuity of Patient Care | 3 | 2015 | 253 | 0.290 |
Why?
| | Safety-net Providers | 2 | 2018 | 95 | 0.290 |
Why?
| | Practice Patterns, Physicians' | 1 | 2015 | 1177 | 0.280 |
Why?
| | Quality of Health Care | 1 | 2011 | 573 | 0.280 |
Why?
| | Female | 35 | 2022 | 59610 | 0.280 |
Why?
| | Case-Control Studies | 7 | 2020 | 3015 | 0.270 |
Why?
| | Mammography | 3 | 2010 | 106 | 0.270 |
Why?
| | Capacity Building | 2 | 2023 | 51 | 0.260 |
Why?
| | Primary Health Care | 4 | 2022 | 1512 | 0.260 |
Why?
| | Adult | 25 | 2019 | 30654 | 0.240 |
Why?
| | Survivorship | 2 | 2022 | 38 | 0.240 |
Why?
| | Odds Ratio | 5 | 2013 | 957 | 0.240 |
Why?
| | Uterine Cervical Neoplasms | 2 | 2014 | 212 | 0.230 |
Why?
| | Arizona | 4 | 2013 | 67 | 0.230 |
Why?
| | Exercise | 1 | 2014 | 1644 | 0.230 |
Why?
| | Healthcare Disparities | 3 | 2017 | 480 | 0.200 |
Why?
| | United States | 14 | 2023 | 12224 | 0.200 |
Why?
| | Risk Factors | 13 | 2023 | 8642 | 0.200 |
Why?
| | Papanicolaou Test | 1 | 1999 | 38 | 0.170 |
Why?
| | Lung Neoplasms | 2 | 2023 | 2201 | 0.170 |
Why?
| | Vaginal Smears | 1 | 1999 | 48 | 0.170 |
Why?
| | Health Priorities | 1 | 1999 | 34 | 0.170 |
Why?
| | Unemployment | 1 | 2019 | 39 | 0.160 |
Why?
| | Research | 3 | 2018 | 395 | 0.160 |
Why?
| | Patient Education as Topic | 2 | 2014 | 682 | 0.160 |
Why?
| | Age Factors | 7 | 2019 | 2894 | 0.150 |
Why?
| | Congresses as Topic | 1 | 2019 | 198 | 0.150 |
Why?
| | Follow-Up Studies | 3 | 2015 | 4420 | 0.140 |
Why?
| | Preventive Medicine | 1 | 2017 | 40 | 0.140 |
Why?
| | Public Health | 1 | 2021 | 435 | 0.140 |
Why?
| | Evidence-Based Practice | 1 | 2018 | 185 | 0.140 |
Why?
| | Comorbidity | 1 | 2020 | 1457 | 0.130 |
Why?
| | Pediatric Obesity | 1 | 2022 | 492 | 0.120 |
Why?
| | Health Planning | 1 | 2015 | 46 | 0.120 |
Why?
| | Health Status | 1 | 2020 | 722 | 0.120 |
Why?
| | Community Health Centers | 1 | 2014 | 54 | 0.120 |
Why?
| | Patient Acceptance of Health Care | 2 | 2018 | 679 | 0.120 |
Why?
| | Transition to Adult Care | 1 | 2015 | 63 | 0.120 |
Why?
| | Diagnostic Tests, Routine | 1 | 2015 | 87 | 0.120 |
Why?
| | Anniversaries and Special Events | 1 | 2014 | 12 | 0.120 |
Why?
| | Disease Management | 2 | 2015 | 563 | 0.120 |
Why?
| | Diffusion of Innovation | 1 | 2014 | 94 | 0.110 |
Why?
| | Health Behavior | 1 | 1999 | 704 | 0.110 |
Why?
| | Ambulatory Care Facilities | 1 | 2015 | 211 | 0.110 |
Why?
| | Body Weight | 2 | 2013 | 873 | 0.110 |
Why?
| | Incidence | 4 | 2019 | 2318 | 0.110 |
Why?
| | Health Promotion | 2 | 2023 | 686 | 0.110 |
Why?
| | Medical Oncology | 1 | 2015 | 227 | 0.110 |
Why?
| | Genetic Testing | 1 | 2015 | 380 | 0.110 |
Why?
| | Age of Onset | 2 | 2019 | 449 | 0.110 |
Why?
| | Receptors, Estrogen | 3 | 2013 | 372 | 0.110 |
Why?
| | New Mexico | 1 | 2013 | 59 | 0.110 |
Why?
| | Vitamin B Complex | 1 | 2013 | 37 | 0.100 |
Why?
| | Health Services Accessibility | 2 | 2014 | 765 | 0.100 |
Why?
| | Health Personnel | 1 | 2018 | 574 | 0.100 |
Why?
| | Receptors, Adrenergic, beta-2 | 1 | 2012 | 41 | 0.100 |
Why?
| | Methionine | 1 | 2013 | 145 | 0.100 |
Why?
| | Prognosis | 3 | 2022 | 3334 | 0.100 |
Why?
| | Socioeconomic Factors | 4 | 2013 | 1081 | 0.100 |
Why?
| | Male | 7 | 2020 | 55729 | 0.100 |
Why?
| | Folic Acid | 1 | 2013 | 159 | 0.100 |
Why?
| | Feasibility Studies | 1 | 2014 | 746 | 0.100 |
Why?
| | Obesity | 3 | 2013 | 2524 | 0.100 |
Why?
| | Patient Participation | 1 | 2014 | 360 | 0.090 |
Why?
| | Guideline Adherence | 1 | 2015 | 492 | 0.090 |
Why?
| | Patient Satisfaction | 1 | 2015 | 580 | 0.090 |
Why?
| | Survival Rate | 2 | 2011 | 1646 | 0.090 |
Why?
| | Interviews as Topic | 2 | 2013 | 583 | 0.090 |
Why?
| | Insulin-Like Growth Factor Binding Protein 3 | 1 | 2009 | 38 | 0.090 |
Why?
| | Southwestern United States | 4 | 2011 | 91 | 0.080 |
Why?
| | Hydroxyestrones | 1 | 2009 | 2 | 0.080 |
Why?
| | Patient Care Team | 1 | 2014 | 515 | 0.080 |
Why?
| | Colorado | 3 | 2015 | 4089 | 0.080 |
Why?
| | Cohort Studies | 2 | 2022 | 4904 | 0.080 |
Why?
| | Confidence Intervals | 1 | 2008 | 306 | 0.070 |
Why?
| | Insulin-Like Growth Factor I | 1 | 2009 | 286 | 0.070 |
Why?
| | Urinary Incontinence | 1 | 2008 | 56 | 0.070 |
Why?
| | Practice Guidelines as Topic | 1 | 2014 | 1398 | 0.070 |
Why?
| | Parity | 2 | 2022 | 98 | 0.070 |
Why?
| | Genetic Predisposition to Disease | 3 | 2010 | 2108 | 0.070 |
Why?
| | Multivariate Analysis | 2 | 1999 | 1435 | 0.070 |
Why?
| | Patient Compliance | 1 | 2009 | 524 | 0.060 |
Why?
| | Reproducibility of Results | 3 | 2018 | 2799 | 0.060 |
Why?
| | Psychometrics | 2 | 2018 | 608 | 0.060 |
Why?
| | Smoking | 2 | 2023 | 1392 | 0.060 |
Why?
| | Phenotype | 1 | 2011 | 2815 | 0.060 |
Why?
| | Biomarkers, Tumor | 1 | 2009 | 1045 | 0.050 |
Why?
| | School Teachers | 1 | 2022 | 18 | 0.050 |
Why?
| | Young Adult | 4 | 2019 | 10498 | 0.050 |
Why?
| | Prospective Studies | 1 | 2013 | 6232 | 0.050 |
Why?
| | Diabetes Mellitus, Type 2 | 2 | 2012 | 2098 | 0.050 |
Why?
| | Alcohol Drinking | 2 | 2011 | 655 | 0.040 |
Why?
| | Diabetes Mellitus | 1 | 2007 | 906 | 0.040 |
Why?
| | Body Mass Index | 3 | 2013 | 1967 | 0.040 |
Why?
| | Postpartum Period | 1 | 2022 | 277 | 0.040 |
Why?
| | School Health Services | 1 | 2022 | 206 | 0.040 |
Why?
| | Proportional Hazards Models | 1 | 2022 | 1080 | 0.040 |
Why?
| | Financing, Personal | 1 | 2019 | 25 | 0.040 |
Why?
| | Minority Groups | 1 | 2000 | 228 | 0.040 |
Why?
| | Culture | 1 | 1999 | 122 | 0.040 |
Why?
| | Health Education | 1 | 2022 | 323 | 0.040 |
Why?
| | Schools | 1 | 2022 | 400 | 0.040 |
Why?
| | Pregnancy | 3 | 2022 | 5519 | 0.040 |
Why?
| | Risk | 2 | 2012 | 815 | 0.040 |
Why?
| | Menopause | 2 | 2011 | 271 | 0.040 |
Why?
| | Postmenopause | 2 | 2009 | 304 | 0.040 |
Why?
| | Factor Analysis, Statistical | 1 | 2018 | 257 | 0.040 |
Why?
| | Medicaid | 1 | 2021 | 409 | 0.040 |
Why?
| | Health Status Disparities | 1 | 2019 | 201 | 0.040 |
Why?
| | Patient Selection | 1 | 2000 | 646 | 0.030 |
Why?
| | Cost of Illness | 1 | 2019 | 254 | 0.030 |
Why?
| | Urban Population | 1 | 1999 | 401 | 0.030 |
Why?
| | Patient Reported Outcome Measures | 1 | 2019 | 250 | 0.030 |
Why?
| | Intersectoral Collaboration | 1 | 2017 | 56 | 0.030 |
Why?
| | Data Collection | 2 | 2014 | 623 | 0.030 |
Why?
| | Risk-Taking | 1 | 1999 | 333 | 0.030 |
Why?
| | Health Care Costs | 1 | 1999 | 381 | 0.030 |
Why?
| | Multicenter Studies as Topic | 1 | 2017 | 250 | 0.030 |
Why?
| | Medicare | 1 | 2021 | 666 | 0.030 |
Why?
| | Health Services Research | 1 | 2018 | 371 | 0.030 |
Why?
| | Prejudice | 1 | 2015 | 56 | 0.030 |
Why?
| | Cancer Care Facilities | 1 | 2015 | 30 | 0.030 |
Why?
| | Poverty | 1 | 2018 | 443 | 0.030 |
Why?
| | Poverty Areas | 1 | 2014 | 32 | 0.030 |
Why?
| | Organizational Innovation | 1 | 2015 | 133 | 0.030 |
Why?
| | Interdisciplinary Communication | 1 | 2015 | 185 | 0.030 |
Why?
| | Insurance Coverage | 1 | 2015 | 201 | 0.030 |
Why?
| | Insurance, Health | 1 | 2015 | 244 | 0.030 |
Why?
| | Program Development | 1 | 2015 | 346 | 0.030 |
Why?
| | Prevalence | 2 | 2010 | 2255 | 0.030 |
Why?
| | Aged, 80 and over | 2 | 2015 | 6357 | 0.030 |
Why?
| | Child | 3 | 2022 | 18407 | 0.020 |
Why?
| | National Cancer Institute (U.S.) | 1 | 2011 | 40 | 0.020 |
Why?
| | Sickness Impact Profile | 1 | 2011 | 50 | 0.020 |
Why?
| | Adolescent | 3 | 2019 | 17862 | 0.020 |
Why?
| | Haplotypes | 1 | 2012 | 455 | 0.020 |
Why?
| | Population Surveillance | 1 | 2013 | 392 | 0.020 |
Why?
| | Neoplasm Staging | 1 | 2013 | 1169 | 0.020 |
Why?
| | Receptors, Progesterone | 1 | 2011 | 319 | 0.020 |
Why?
| | Premenopause | 1 | 2009 | 107 | 0.020 |
Why?
| | Receptor, ErbB-2 | 1 | 2011 | 300 | 0.020 |
Why?
| | Decision Making | 1 | 2015 | 782 | 0.020 |
Why?
| | Body Composition | 1 | 2013 | 586 | 0.020 |
Why?
| | Body Size | 1 | 2009 | 91 | 0.020 |
Why?
| | Epidemiologic Methods | 1 | 2008 | 72 | 0.020 |
Why?
| | Adaptation, Physiological | 1 | 2011 | 481 | 0.020 |
Why?
| | Societies, Medical | 1 | 2011 | 678 | 0.020 |
Why?
| | Chi-Square Distribution | 1 | 2008 | 498 | 0.020 |
Why?
| | Women's Health | 1 | 2009 | 271 | 0.020 |
Why?
| | Risk Assessment | 1 | 2015 | 2976 | 0.020 |
Why?
| | Motor Activity | 1 | 2011 | 642 | 0.020 |
Why?
| | Attitude to Health | 1 | 2009 | 405 | 0.020 |
Why?
| | Retrospective Studies | 1 | 2021 | 12547 | 0.010 |
Why?
| | Diabetes, Gestational | 1 | 2007 | 281 | 0.010 |
Why?
| | Child, Preschool | 1 | 2015 | 9093 | 0.010 |
Why?
| | Cultural Characteristics | 1 | 2000 | 59 | 0.010 |
Why?
| | Language | 1 | 2000 | 258 | 0.010 |
Why?
|
|
Risendal's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|